Safety Shot’s Game Changing Blood Alcohol Reduction Beverage to Hit 7-Eleven Stores in Chicago
Rhea-AI Summary
Safety Shot, Inc. (Nasdaq: SHOT) has announced that its 4 oz. bottles of Safety Shot, the world's first beverage to reduce blood alcohol content, will soon be available at 315 7-Eleven stores in the Chicago area. This partnership, established with the Franchise Owners Association (FOA) Chicago, will see the product placed on countertops, priced at $5.99 each or $10 for two.
7-Eleven, the world's largest convenience store chain with over 12,000 U.S. locations and $72 billion in sales last year, is an ideal platform for Safety Shot's commercialization efforts. The launch timing coincides with the fourth quarter, traditionally a peak period for alcohol sales due to holiday gatherings and seasonal stress.
CEO Jarrett Boon emphasized the strategic importance of this distribution in a major metropolis, particularly during a high-demand season for alcohol. The company plans to evaluate further strategic launches for its on-the-go bottles.
Positive
- Partnership with 7-Eleven to distribute Safety Shot in 315 Chicago area stores
- Strategic timing of launch during peak alcohol sales season (Q4)
- Prominent counter-top placement in high-traffic convenience stores
- Expansion into the third largest metropolitan area in the United States
Negative
- None.
Insights
The launch of Safety Shot's blood alcohol reduction beverage in 315 7-Eleven stores across Chicago marks a significant milestone for the company's market penetration strategy. This partnership with a major convenience store chain in the third-largest U.S. metropolitan area provides Safety Shot with substantial exposure to a large consumer base.
The timing of this launch is strategically aligned with the seasonal increase in alcohol sales during the fall and winter holidays. With a
However, investors should consider that:
- The product's efficacy and consumer acceptance are yet to be proven on a large scale
- Regulatory scrutiny may increase as the product gains visibility
- The impact on Safety Shot's revenue and profitability will depend on sales performance and distribution costs
While this launch is promising, it represents a test market rather than a nationwide rollout. The success in Chicago will likely determine future expansion opportunities with 7-Eleven and other retailers.
This distribution deal with 7-Eleven is a positive development for Safety Shot, Inc. (NASDAQ: SHOT), potentially impacting its financial outlook. Here's why:
- Increased Revenue Potential: With a presence in 315 high-traffic locations, Safety Shot could see a significant boost in sales. Assuming conservative estimates of 10 units sold per store per day at
$5.99 each, this could translate to additional annual revenue of approximately$6.9 million . - Brand Visibility: The counter-top placement in 7-Eleven stores provides premium visibility, which could drive brand awareness and lead to increased demand in other channels.
- Market Validation: Partnership with a major retailer like 7-Eleven lends credibility to Safety Shot's product, potentially attracting other retail partners.
However, investors should note that Safety Shot's current market cap of
Safety Shot 4 oz. bottles will be sold at the world's first convenience retailer at over 300 locations in the Chicago area.
JUPITER, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”) is excited to announce that 4 oz. bottles of Safety Shot, the world’s first beverage to reduce blood alcohol content, will soon be sold at 7-Eleven convenience stores in the Chicago area.
Working in a partnership with the President and board members of the Francise Owners Association (FOA) Chicago, Safety Shot will launch its convenient on-the-go 4 oz. bottles at 315 7-Eleven stores in the Chicago area.
The product will have a counter-top placement and will be priced at
In 1927, 7-Eleven showed the world just how convenient shopping could be and has been doing it every day since. 7-Eleven is the world's largest convenience store chain with more than 12,000 locations in the U.S. alone and generated

Many retailers report their highest alcohol sales in the fourth quarter of the year (from October until New Years Eve). With the large number of holiday gatherings—not to mention the added stress of the season— the fall and winter holidays are one of the most popular times for alcohol use.
“To be distributed in one of the most recognized convenience stores is monumental in driving Safety Shot’s commercialization efforts. The fall and winter seasons see an uptick in alcohol sales making it the best time for Safety Shot to be on the countertops of over 300 7-Eleven stores in a large metropolis city,” stated Safety Shot CEO Jarrett Boon. “The Chicago area is the third largest metropolitan area in the United States and the fourth largest metropolitan area in North America. We will continue to evaluate more strategic launches for Safety Shot’s easy on-the-go bottles.”
For more information on Safety Shot, visit www.drinksafetyshot.com and Amazon.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot's ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot's future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," or "would" or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market Safety Shot and the risks and uncertainties that are described more fully in the section titled "Risk Factors" in Safety Shot's Form 10-Q for the fiscal year ended June 30, 2024, filed with the Securities and Exchange Commission on August 15, 2024, and its other filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Safety Shot undertakes no duty to update such information except as required under applicable law.
Media and Investor Contact:
Autumn Communications
Jess Weinberger
Phone: 201-213-3239
Email: shot@autumncommunications.com
Investor Relations
Medon Michaelides
Phone: 561-244-7100
Email: investors@drinksafetyshot.com